NIH National Cancer Institute logo
NCI SBIR/STTR Omnibus (NIH-wide) + NCI SBIR Contracts

NCI SBIR/STTR Omnibus (Next Receipt 5)

Supports small businesses developing cancer technologies through national NIH collaboration pathways.

OpenNIH National Cancer InstituteUnited States
Apply on funder portal
About

The NCI Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) Omnibus is the primary non-dilutive federal funding mechanism for US small businesses developing cancer-relevant technologies. NCI participates as a contributing Institute in the NIH-wide SBIR/STTR Omnibus administered by NIH OER/SEED. Covered mechanisms are R43 (SBIR Phase I), R44 (SBIR Phase II), R41 (S…

What this grant funds

Cancer diagnostics, therapeutics, devices, digital health, and research tools. Any cancer-relevant innovation area.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.5 Sept 2026
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.6–24 months
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Application process

Sign up free to see how to apply

Create free accountSign in
What you have to submit

Sign up free to see what you submit

Create free accountSign in
Timeline

Sign up free to see the timeline

Create free accountSign in
Last verified: 22 Jul 2026Source: sbir.cancer.gov